Skip to main content
OpenTrials
Completed

NCT Number: NCT05095883

Correlation Between Body Weight and Foot Progression Angle in Adolescents

Obesity is associated with functional decline , altered spatiotemporal gait parameters (e.g. lower gait speed, shorter strides, and increased step width), and a significantly higher metabolic cost of walking compared to people with normal body weight. Obesity also negatively affects balance control.This study will investigate foot progression angle in adolescents related to their weight and category classification based on the CDC (Centers for Disease Control and Prevention) growth charts.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obesity, Adolescent Adolescent Development Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Pediatric Obesity Signs and Symptoms

Age range

13 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

AAA

Cairo, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All children have normal stature for age percentile according to CDC chart.
  • The sample will include both sex and will be divided in to 4 groups according to the CDC (Centers for Disease Control and Prevention) growth charts.
  • All children are normal &perform all activities of daily living
  • They were able to understand and follow verbal commands and instructions included in the testing procedures.

Exclusion criteria

  • All of them could be part of recreational activities in their public schools but no competitive sports. Children who participated in any regular sport activities involving the lower extremities will be excluded.
  • None of them had any surgical intervention in the lower extremities.
  • None of them had any history of musculoskeletal deformities or neuromuscular disorders.
  • They had neither visual, auditory defect.

Treatment and study plan

Primary outcomes

  1. foot progression angle for healthy group

    Time frame: assessed immediately after the procedure

    participants in healthy group will be assessed for foot progression angle (FPA). The FPA is defined as the angle made by the long axis of the foot from the heel to 2nd metatarsal and the line of progression of gait

  2. foot progression angle for overweight group

    Time frame: assessed immediately after the procedure

    participants in overweight group will be assessed for foot progression angle (FPA). The FPA is defined as the angle made by the long axis of the foot from the heel to 2nd metatarsal and the line of progression of gait.

  3. foot progression angle for obese group

    Time frame: assessed immediately after the procedure

    participants in obese group will be assessed for foot progression angle (FPA). The FPA is defined as the angle made by the long axis of the foot from the heel to 2nd metatarsal and the line of progression of gait.

  4. foot progression angle for underweight group

    Time frame: assessed immediately after the procedure

    participants in underweight group will be assessed for foot progression angle (FPA). The FPA is defined as the angle made by the long axis of the foot from the heel to 2nd metatarsal and the line of progression of gait.

Sponsors and collaborators

Lead sponsor

Delta University for Science and Technology

Other

Registry information

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Oct 27, 2021
Registry last updated
Jan 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.